nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—SIRT1—brain cancer	0.812	1	CbGaD
Suramin—FSHR—hindbrain—brain cancer	0.00585	0.0584	CbGeAlD
Suramin—F2—vein—brain cancer	0.00557	0.0555	CbGeAlD
Suramin—SIRT5—ganglion—brain cancer	0.00507	0.0506	CbGeAlD
Suramin—SIRT1—endothelium—brain cancer	0.00362	0.0361	CbGeAlD
Suramin—SIRT1—blood vessel—brain cancer	0.00334	0.0333	CbGeAlD
Suramin—FSHR—gonad—brain cancer	0.00248	0.0248	CbGeAlD
Suramin—FSHR—pituitary gland—brain cancer	0.00242	0.0242	CbGeAlD
Suramin—P2RY2—endocrine gland—brain cancer	0.002	0.0199	CbGeAlD
Suramin—P2RY2—head—brain cancer	0.00197	0.0197	CbGeAlD
Suramin—SIRT5—telencephalon—brain cancer	0.00196	0.0195	CbGeAlD
Suramin—F2—endothelium—brain cancer	0.00191	0.0191	CbGeAlD
Suramin—FSHR—endocrine gland—brain cancer	0.00188	0.0187	CbGeAlD
Suramin—F2—blood vessel—brain cancer	0.00177	0.0176	CbGeAlD
Suramin—FSHR—cerebellum—brain cancer	0.00165	0.0165	CbGeAlD
Suramin—SIRT5—gonad—brain cancer	0.00163	0.0163	CbGeAlD
Suramin—SIRT1—telencephalon—brain cancer	0.00162	0.0162	CbGeAlD
Suramin—SIRT5—pituitary gland—brain cancer	0.00159	0.0159	CbGeAlD
Suramin—SIRT5—medulla oblongata—brain cancer	0.00154	0.0153	CbGeAlD
Suramin—P2RX4—pituitary gland—brain cancer	0.00151	0.015	CbGeAlD
Suramin—P2RX4—medulla oblongata—brain cancer	0.00145	0.0145	CbGeAlD
Suramin—SIRT1—gonad—brain cancer	0.00135	0.0135	CbGeAlD
Suramin—ARSA—gonad—brain cancer	0.00134	0.0133	CbGeAlD
Suramin—SIRT1—pituitary gland—brain cancer	0.00132	0.0132	CbGeAlD
Suramin—ARSA—pituitary gland—brain cancer	0.0013	0.013	CbGeAlD
Suramin—P2RX4—spinal cord—brain cancer	0.0013	0.0129	CbGeAlD
Suramin—SIRT1—medulla oblongata—brain cancer	0.00127	0.0127	CbGeAlD
Suramin—SIRT5—endocrine gland—brain cancer	0.00123	0.0123	CbGeAlD
Suramin—SIRT5—head—brain cancer	0.00122	0.0122	CbGeAlD
Suramin—RYR1—medulla oblongata—brain cancer	0.00118	0.0117	CbGeAlD
Suramin—P2RX4—endocrine gland—brain cancer	0.00117	0.0116	CbGeAlD
Suramin—SIRT1—midbrain—brain cancer	0.00116	0.0116	CbGeAlD
Suramin—P2RX4—head—brain cancer	0.00115	0.0115	CbGeAlD
Suramin—SIRT1—spinal cord—brain cancer	0.00114	0.0113	CbGeAlD
Suramin—PLA2G2A—telencephalon—brain cancer	0.00113	0.0113	CbGeAlD
Suramin—ARSA—spinal cord—brain cancer	0.00112	0.0112	CbGeAlD
Suramin—SIRT5—central nervous system—brain cancer	0.00111	0.0111	CbGeAlD
Suramin—SIRT5—cerebellum—brain cancer	0.00109	0.0108	CbGeAlD
Suramin—RYR1—midbrain—brain cancer	0.00108	0.0107	CbGeAlD
Suramin—P2RX4—central nervous system—brain cancer	0.00105	0.0105	CbGeAlD
Suramin—P2RX4—cerebellum—brain cancer	0.00103	0.0103	CbGeAlD
Suramin—SIRT1—endocrine gland—brain cancer	0.00102	0.0102	CbGeAlD
Suramin—ARSA—endocrine gland—brain cancer	0.00101	0.0101	CbGeAlD
Suramin—SIRT1—head—brain cancer	0.00101	0.0101	CbGeAlD
Suramin—ARSA—head—brain cancer	0.000997	0.00995	CbGeAlD
Suramin—RYR1—endocrine gland—brain cancer	0.000944	0.00942	CbGeAlD
Suramin—RYR1—head—brain cancer	0.000932	0.0093	CbGeAlD
Suramin—PLA2G2A—pituitary gland—brain cancer	0.000924	0.00922	CbGeAlD
Suramin—SIRT1—central nervous system—brain cancer	0.000921	0.00919	CbGeAlD
Suramin—ARSA—central nervous system—brain cancer	0.00091	0.00908	CbGeAlD
Suramin—SIRT1—cerebellum—brain cancer	0.0009	0.00898	CbGeAlD
Suramin—ARSA—cerebellum—brain cancer	0.000889	0.00887	CbGeAlD
Suramin—SIRT5—brain—brain cancer	0.000883	0.00881	CbGeAlD
Suramin—RYR1—central nervous system—brain cancer	0.000851	0.00849	CbGeAlD
Suramin—P2RX4—brain—brain cancer	0.000835	0.00833	CbGeAlD
Suramin—RYR1—cerebellum—brain cancer	0.000832	0.0083	CbGeAlD
Suramin—PLA2G2A—midbrain—brain cancer	0.000815	0.00813	CbGeAlD
Suramin—SIRT1—brain—brain cancer	0.000731	0.0073	CbGeAlD
Suramin—ARSA—brain—brain cancer	0.000722	0.00721	CbGeAlD
Suramin—PLA2G2A—endocrine gland—brain cancer	0.000716	0.00714	CbGeAlD
Suramin—PLA2G2A—head—brain cancer	0.000707	0.00705	CbGeAlD
Suramin—RYR1—brain—brain cancer	0.000676	0.00674	CbGeAlD
Suramin—PLA2G2A—central nervous system—brain cancer	0.000645	0.00644	CbGeAlD
Suramin—PLA2G4A—pituitary gland—brain cancer	0.000642	0.00641	CbGeAlD
Suramin—PLA2G4A—medulla oblongata—brain cancer	0.00062	0.00619	CbGeAlD
Suramin—F2—spinal cord—brain cancer	0.0006	0.00599	CbGeAlD
Suramin—PLA2G4A—midbrain—brain cancer	0.000567	0.00565	CbGeAlD
Suramin—PLA2G4A—spinal cord—brain cancer	0.000553	0.00552	CbGeAlD
Suramin—F2—endocrine gland—brain cancer	0.00054	0.00539	CbGeAlD
Suramin—F2—head—brain cancer	0.000533	0.00532	CbGeAlD
Suramin—PLA2G2A—brain—brain cancer	0.000512	0.00511	CbGeAlD
Suramin—PLA2G4A—endocrine gland—brain cancer	0.000498	0.00497	CbGeAlD
Suramin—F2—central nervous system—brain cancer	0.000487	0.00486	CbGeAlD
Suramin—PLA2G4A—central nervous system—brain cancer	0.000448	0.00447	CbGeAlD
Suramin—F2—brain—brain cancer	0.000387	0.00386	CbGeAlD
Suramin—PLA2G4A—brain—brain cancer	0.000356	0.00355	CbGeAlD
Suramin—FSHR—Signaling Pathways—GLI1—brain cancer	0.00013	0.00148	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—OR4C12—brain cancer	0.00013	0.00147	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—OR14C36—brain cancer	0.00013	0.00147	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000129	0.00147	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MYC—brain cancer	0.000129	0.00146	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SUFU—brain cancer	0.000128	0.00145	CbGpPWpGaD
Suramin—ARSA—Metabolism—IDH1—brain cancer	0.000127	0.00144	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—VAV1—brain cancer	0.000127	0.00144	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—EGFR—brain cancer	0.000126	0.00143	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SUFU—brain cancer	0.000123	0.0014	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GFAP—brain cancer	0.000123	0.0014	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000122	0.00138	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000121	0.00137	CbGpPWpGaD
Suramin—F2—Hemostasis—BSG—brain cancer	0.000121	0.00137	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000119	0.00135	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—RELA—brain cancer	0.000119	0.00135	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—VAV1—brain cancer	0.000119	0.00135	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GFAP—brain cancer	0.000119	0.00135	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000118	0.00134	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HEY1—brain cancer	0.000117	0.00132	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000115	0.00131	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—VAV1—brain cancer	0.000115	0.00131	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DLL1—brain cancer	0.000115	0.0013	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HEY1—brain cancer	0.000113	0.00128	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP2C9—brain cancer	0.000112	0.00127	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DLL1—brain cancer	0.000111	0.00125	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—BSG—brain cancer	0.000111	0.00125	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000108	0.00122	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—brain cancer	0.000106	0.0012	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000106	0.0012	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CG—brain cancer	0.000106	0.0012	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000105	0.00119	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000104	0.00118	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—STAT3—brain cancer	0.000104	0.00118	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000103	0.00117	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—DNMT1—brain cancer	0.000103	0.00117	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—VEGFA—brain cancer	0.000102	0.00116	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—STAT3—brain cancer	0.000101	0.00115	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—brain cancer	0.0001	0.00114	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.0001	0.00114	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—APC—brain cancer	0.0001	0.00114	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.0001	0.00114	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SHH—brain cancer	9.75e-05	0.0011	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—PIK3CG—brain cancer	9.75e-05	0.0011	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.69e-05	0.0011	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—brain cancer	9.63e-05	0.00109	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—BSG—brain cancer	9.51e-05	0.00108	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—brain cancer	9.46e-05	0.00107	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SHH—brain cancer	9.41e-05	0.00107	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TRPC6—brain cancer	9.4e-05	0.00107	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ESR2—brain cancer	9.26e-05	0.00105	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SMO—brain cancer	9.24e-05	0.00105	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTCH1—brain cancer	9.24e-05	0.00105	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	9.24e-05	0.00105	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SHH—brain cancer	9.19e-05	0.00104	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTCH2—brain cancer	9.15e-05	0.00104	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TRPC6—brain cancer	9.08e-05	0.00103	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTCH1—brain cancer	8.92e-05	0.00101	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SMO—brain cancer	8.92e-05	0.00101	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NOTCH2—brain cancer	8.77e-05	0.000994	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SMO—brain cancer	8.71e-05	0.000987	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTCH1—brain cancer	8.71e-05	0.000987	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—brain cancer	8.69e-05	0.000985	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.65e-05	0.000981	CbGpPWpGaD
Suramin—F2—Signaling Pathways—OR4C12—brain cancer	8.39e-05	0.000951	CbGpPWpGaD
Suramin—F2—Signaling Pathways—OR14C36—brain cancer	8.39e-05	0.000951	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTCH2—brain cancer	8.37e-05	0.000949	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—PIK3CG—brain cancer	8.34e-05	0.000945	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—IDH1—brain cancer	8.18e-05	0.000927	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—PIK3CG—brain cancer	8.05e-05	0.000912	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.98e-05	0.000905	CbGpPWpGaD
Suramin—F2—Hemostasis—TRPC6—brain cancer	7.92e-05	0.000898	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ABR—brain cancer	7.91e-05	0.000896	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—brain cancer	7.74e-05	0.000878	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—OR4C12—brain cancer	7.67e-05	0.00087	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—OR14C36—brain cancer	7.67e-05	0.00087	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PIK3CG—brain cancer	7.57e-05	0.000858	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.52e-05	0.000852	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NOTCH2—brain cancer	7.39e-05	0.000837	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	7.31e-05	0.000829	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PIK3CG—brain cancer	7.31e-05	0.000829	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TRPC6—brain cancer	7.25e-05	0.000821	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ABR—brain cancer	7.18e-05	0.000814	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DTX2—brain cancer	7.13e-05	0.000809	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NOTCH2—brain cancer	7.13e-05	0.000809	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VAV1—brain cancer	7.04e-05	0.000798	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VAV1—brain cancer	6.8e-05	0.000771	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.69e-05	0.000758	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.66e-05	0.000755	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ABR—brain cancer	6.57e-05	0.000745	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DTX2—brain cancer	6.53e-05	0.00074	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—brain cancer	6.47e-05	0.000733	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—brain cancer	6.25e-05	0.000708	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CTNNB1—brain cancer	6.07e-05	0.000688	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HES1—brain cancer	6.06e-05	0.000687	CbGpPWpGaD
Suramin—F2—Hemostasis—VAV1—brain cancer	5.94e-05	0.000673	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—IL2—brain cancer	5.87e-05	0.000665	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HES1—brain cancer	5.85e-05	0.000663	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.84e-05	0.000661	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—brain cancer	5.81e-05	0.000658	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PDGFRA—brain cancer	5.77e-05	0.000654	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—IL2—brain cancer	5.67e-05	0.000642	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SPP1—brain cancer	5.6e-05	0.000635	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PDGFRA—brain cancer	5.57e-05	0.000631	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VAV1—brain cancer	5.43e-05	0.000615	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SPP1—brain cancer	5.41e-05	0.000613	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH2—brain cancer	5.41e-05	0.000613	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	5.39e-05	0.000611	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL2—brain cancer	5.33e-05	0.000604	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP2C9—brain cancer	5.27e-05	0.000597	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HES5—brain cancer	5.24e-05	0.000594	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.16e-05	0.000584	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IL2—brain cancer	5.15e-05	0.000583	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL2—brain cancer	5.14e-05	0.000583	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.11e-05	0.000579	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STRADA—brain cancer	5.08e-05	0.000576	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IRS2—brain cancer	5.06e-05	0.000574	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TRPC6—brain cancer	5.01e-05	0.000568	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH2—brain cancer	4.95e-05	0.000561	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IRS2—brain cancer	4.89e-05	0.000554	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HES5—brain cancer	4.79e-05	0.000543	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SHH—brain cancer	4.72e-05	0.000534	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—brain cancer	4.71e-05	0.000533	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STRADA—brain cancer	4.65e-05	0.000527	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3CG—brain cancer	4.6e-05	0.000522	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TRPC6—brain cancer	4.55e-05	0.000515	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.49e-05	0.000509	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—BSG—brain cancer	4.48e-05	0.000508	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CG—brain cancer	4.47e-05	0.000507	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APC—brain cancer	4.47e-05	0.000507	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SMO—brain cancer	4.47e-05	0.000507	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTCH1—brain cancer	4.47e-05	0.000507	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.37e-05	0.000496	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APC—brain cancer	4.32e-05	0.000489	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CG—brain cancer	4.32e-05	0.000489	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SHH—brain cancer	4.31e-05	0.000489	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ABR—brain cancer	4.24e-05	0.000481	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TRPC6—brain cancer	4.16e-05	0.000471	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.14e-05	0.000469	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GLI2—brain cancer	4.1e-05	0.000464	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SMO—brain cancer	4.09e-05	0.000463	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTCH1—brain cancer	4.09e-05	0.000463	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—brain cancer	4.07e-05	0.000462	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.04e-05	0.000458	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.02e-05	0.000456	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4e-05	0.000453	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—brain cancer	3.93e-05	0.000446	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ABR—brain cancer	3.88e-05	0.00044	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—IDH1—brain cancer	3.85e-05	0.000437	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GLI1—brain cancer	3.85e-05	0.000437	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CG—brain cancer	3.77e-05	0.000427	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—VAV1—brain cancer	3.75e-05	0.000425	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GLI2—brain cancer	3.75e-05	0.000425	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SUFU—brain cancer	3.65e-05	0.000414	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GLI1—brain cancer	3.52e-05	0.000399	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GFAP—brain cancer	3.52e-05	0.000399	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RELA—brain cancer	3.49e-05	0.000396	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ERBB2—brain cancer	3.47e-05	0.000394	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CG—brain cancer	3.45e-05	0.000391	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—VAV1—brain cancer	3.41e-05	0.000386	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.4e-05	0.000385	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RELA—brain cancer	3.37e-05	0.000382	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB2—brain cancer	3.35e-05	0.00038	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SUFU—brain cancer	3.34e-05	0.000379	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HEY1—brain cancer	3.34e-05	0.000379	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DLL1—brain cancer	3.28e-05	0.000371	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GFAP—brain cancer	3.22e-05	0.000365	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2—brain cancer	3.15e-05	0.000357	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.14e-05	0.000356	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—VAV1—brain cancer	3.12e-05	0.000353	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—brain cancer	3.07e-05	0.000348	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HEY1—brain cancer	3.06e-05	0.000346	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—brain cancer	3.05e-05	0.000345	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2—brain cancer	3.04e-05	0.000344	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—brain cancer	3.04e-05	0.000344	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DLL1—brain cancer	3e-05	0.00034	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CG—brain cancer	2.97e-05	0.000336	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—brain cancer	2.96e-05	0.000336	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—brain cancer	2.93e-05	0.000333	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—brain cancer	2.92e-05	0.000331	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SHH—brain cancer	2.79e-05	0.000316	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TRPC6—brain cancer	2.69e-05	0.000304	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—brain cancer	2.67e-05	0.000303	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2—brain cancer	2.65e-05	0.000301	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—brain cancer	2.65e-05	0.0003	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH1—brain cancer	2.64e-05	0.000299	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMO—brain cancer	2.64e-05	0.000299	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—brain cancer	2.58e-05	0.000293	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—brain cancer	2.56e-05	0.00029	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SHH—brain cancer	2.55e-05	0.000289	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—brain cancer	2.46e-05	0.000279	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TRPC6—brain cancer	2.46e-05	0.000278	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2—brain cancer	2.43e-05	0.000275	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH1—brain cancer	2.42e-05	0.000274	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMO—brain cancer	2.42e-05	0.000274	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—brain cancer	2.41e-05	0.000273	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CG—brain cancer	2.38e-05	0.00027	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—brain cancer	2.38e-05	0.000269	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—brain cancer	2.32e-05	0.000263	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—brain cancer	2.25e-05	0.000255	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CG—brain cancer	2.16e-05	0.000245	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH2—brain cancer	2.11e-05	0.000239	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—brain cancer	2.06e-05	0.000234	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—brain cancer	2.02e-05	0.000229	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—brain cancer	2.01e-05	0.000228	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VAV1—brain cancer	2.01e-05	0.000228	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CG—brain cancer	1.98e-05	0.000224	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—brain cancer	1.95e-05	0.000221	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH2—brain cancer	1.93e-05	0.000219	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VAV1—brain cancer	1.84e-05	0.000209	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HES1—brain cancer	1.73e-05	0.000196	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—brain cancer	1.7e-05	0.000193	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2—brain cancer	1.68e-05	0.00019	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDGFRA—brain cancer	1.65e-05	0.000187	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SPP1—brain cancer	1.6e-05	0.000181	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HES1—brain cancer	1.58e-05	0.000179	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—brain cancer	1.56e-05	0.000177	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2—brain cancer	1.52e-05	0.000173	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDGFRA—brain cancer	1.51e-05	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000166	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS2—brain cancer	1.45e-05	0.000164	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CG—brain cancer	1.4e-05	0.000158	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2—brain cancer	1.39e-05	0.000158	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS2—brain cancer	1.32e-05	0.00015	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CG—brain cancer	1.28e-05	0.000145	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APC—brain cancer	1.28e-05	0.000145	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APC—brain cancer	1.17e-05	0.000132	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CG—brain cancer	1.17e-05	0.000132	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—brain cancer	1.16e-05	0.000132	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—brain cancer	1.06e-05	0.000121	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RELA—brain cancer	9.98e-06	0.000113	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB2—brain cancer	9.92e-06	0.000112	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RELA—brain cancer	9.13e-06	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB2—brain cancer	9.07e-06	0.000103	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2—brain cancer	8.99e-06	0.000102	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—brain cancer	8.77e-06	9.94e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—brain cancer	8.68e-06	9.84e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2—brain cancer	8.22e-06	9.32e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—brain cancer	8.02e-06	9.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—brain cancer	7.94e-06	9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—brain cancer	7.64e-06	8.66e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—brain cancer	7.57e-06	8.58e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—brain cancer	7.03e-06	7.97e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—brain cancer	6.99e-06	7.92e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—brain cancer	6.92e-06	7.84e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—brain cancer	6.88e-06	7.79e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—brain cancer	6.43e-06	7.29e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—brain cancer	6.29e-06	7.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—brain cancer	5.77e-06	6.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—brain cancer	5.28e-06	5.99e-05	CbGpPWpGaD
